Skip to main content
Acorda Therapeutics, Inc. (ACORQ)
Aug 22, 2024 - ACORQ was delisted (reason: shares cancelled)
0.0100
0.00 (0.00%)
Inactive · Last trade price on Aug 23, 2024

Acorda Therapeutics Revenue

Acorda Therapeutics had revenue of $20.29M in the quarter ending March 31, 2024, a decrease of -8.85%. This brings the company's revenue in the last twelve months to $115.66M, down -2.22% year-over-year. In the year 2023, Acorda Therapeutics had annual revenue of $117.63M, down -0.79%.

Revenue (ttm)
$115.66M
Revenue Growth
-2.22%
P/S Ratio
0.00
Revenue / Employee
$1,133,961
Employees
102
Market Cap
12.42K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023117.63M-933.00K-0.79%
Dec 31, 2022118.57M-10.51M-8.14%
Dec 31, 2021129.07M-23.90M-15.62%
Dec 31, 2020152.97M-39.44M-20.50%
Dec 31, 2019192.41M-279.03M-59.19%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ACORQ News

More News